Paramount Global announces layoffs, merger with Skydance Media faces complications from Trump lawsuit and regulatory delays.
Insmed's stock surges 27% after positive Phase 2b trial results for its pulmonary hypertension treatment, positioning it as a potential breakthrough therapy.
Paramount Global announces layoffs, merger with Skydance Media faces complications from Trump lawsuit and regulatory delays.
Insmed's stock surges 27% after positive Phase 2b trial results for its pulmonary hypertension treatment, positioning it as a potential breakthrough therapy.